Medical Research
(H80)
990 on File
OXFENDAZOLE DEVELOPMENT GROUP
Financial strength (30%)
64/100
Reliability (20%)
50/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$9K
Total Revenue
$227K
Total Expenses
$100K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
99.4%
Fundraising Efficiency
N/A
Operating Reserve
5.30x
Liability-to-Asset
0.0%
Revenue Diversification
89.1%
Executive Compensation
$0
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
99.4% | 84.6% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
0.6% | 10.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
5.3 mo | 11.7 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
89.1% | 92.2% |
P10P90
|
Above median |
|
Surplus margin
Surplus as a share of revenue
|
-2534.9% | -1.6% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $9K | $227K | $100K | 99.4% | 0 |
| 2023 | $59K | $605K | $1.1M | 98.0% | 0 |
| 2022 | $1.7M | $43K | $1.7M | 95.9% | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.